🇺🇸 FDA
Pipeline program

Sublingual film containing Igalmi

BXCL501-404

Approved small_molecule completed

Quick answer

Sublingual film containing Igalmi for Bipolar Disorder is a Approved program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
BioXcel Therapeutics
Indication
Bipolar Disorder
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials